CNIO - Spanish National Cancer Research Centre
Jose Antonio Torres is a skilled researcher currently serving as a PhD Student in the Molecular Oncology Programme and a Research Assistant in the Drug Discovery Programme at the Spanish National Cancer Research Centre (CNIO) since September 2019. With a strong background in molecular oncology, biology, and pharmacological research, Jose has experience in LC-MS/MS, ADME, PK/PD studies in mice, and the development of PROTACs. Previous roles include a faculty member at Universidad del Atlántico Medio, where tutoring for master thesis students was a primary responsibility, and private tutoring in sciences and mathematics. Jose completed a master's thesis at CNIO focusing on drug development methods and pharmacokinetics and holds multiple degrees, including a Master's in Pharmacological Research from Universidad Autónoma de Madrid and a Bachelor's in Biochemistry from Universidad de Málaga. Additional training includes a Stem Cell Course at Takara Bio Gothenburg and participation in the Erasmus+ programme in Sweden.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.